Skip to Content

Join the 'Chronic Spasticity' group to help and get support from people like you.

Chronic Spasticity News

Paralyzed Man Walks Using Technology That Bypasses Spinal Cord

Posted 10 days ago by

THURSDAY, Sept. 24, 2015 – A paralyzed 26-year-old man has walked for the first time in five years, thanks to an electrical system that connects his brain and legs, bypassing his injured spine, researchers are reporting. The unidentified man is the first person to show that a system like this might help people with a spinal cord injury regain some ability to walk, the researchers said. "The work does offer exciting promise," said Randy Trumbower, an assistant professor in the department of rehabilitation medicine at Emory University School of Medicine in Atlanta, who was not involved with the research. That said, it "must overcome several hurdles before it may be applicable to a broad population of persons with spinal cord injury," he added. Study authors An Do and Zoran Nenadic, both at the University of California, Irvine, said they don't yet know how the system will work in a larger ... Read more

Related support groups: Spinal Cord Trauma, Chronic Spasticity, Central Nervous System Disorders, Paralytic Disorder

FDA Approves Movement Disorder Drug from CNS Therapeutics: Gablofen (Baclofen Injection) for the Treatment of Severe Spasticity

Posted 23 Nov 2010 by

ST. PAUL, Minn.--(BUSINESS WIRE)--Nov 23, 2010 - Today, CNS Therapeutics announced the FDA approval of Gablofen (baclofen injection) for use in the management of severe spasticity, giving healthcare providers a new, easy-to-administer and cost-effective intrathecal baclofen treatment option. Severe spasticity is a movement disorder affecting more than 500,000 patients in the U.S. alone and is often brought on by multiple sclerosis, cerebral palsy, spinal cord injury, brain trauma and stroke. Richard Penn, M.D., a pioneer in intrathecal drug therapies and CNS Therapeutics co-founder and chief scientific officer, implanted the industry's first programmable intrathecal drug pump more than 25 years ago. "Until now, the evolution of intrathecal therapies has been limited to modest innovations in implantable devices," said Penn. "With Gablofen, CNS Therapeutics is driving the industry ahead ... Read more

Related support groups: Baclofen, Chronic Spasticity, Cerebral Spasticity

Botox (onabotulinumtoxinA) Receives FDA Approval for Treatment of Upper Limb Spasticity in Adults

Posted 10 Mar 2010 by

IRVINE, Calif.--(BUSINESS WIRE)--Mar 10, 2010 - Allergan, Inc. today announced that the United States Food and Drug Administration (FDA) has approved Botox (onabotulinumtoxinA) for the treatment of increased muscle stiffness in the elbow, wrist and fingers in adults with upper limb spasticity. Spasticity is a debilitating condition impacting approximately 1 million Americans1, many of whom suffer from spasticity in the upper limbs following a stroke. Upper limb spasticity may also occur following a spinal cord or traumatic brain injury or in patients affected by multiple sclerosis or adults with a history of cerebral palsy. Although not a life-threatening condition, upper limb spasticity can be severely debilitating and painful, producing disfiguring muscle contractions that can result in stiff, tight muscles in the elbow, wrist and fingers, or a clenched fist. This stiffness hinders a ... Read more

Related support groups: Botox, Chronic Spasticity, Botulinum Toxin Type A

Ask a Question

Further Information

Related Condition Support Groups

Upper Limb Spasticity, Multiple Sclerosis

Related Drug Support Groups

baclofen, Botox, dantrolene, Lioresal, Dantrium, Gablofen, Lioresal Intrathecal, onabotulinumtoxina, Revonto, Dantrium Intravenous, Kemstro